241![Microsoft Word - Conflict Report.doc Microsoft Word - Conflict Report.doc](https://www.pdfsearch.io/img/c4ae6db5950390af415e506e02a85929.jpg) | Add to Reading ListSource URL: www.lymediseaseassociation.orgLanguage: English - Date: 2010-07-12 19:38:02
|
---|
242![Delaware Division of Public Health Bureau of Epidemiology Lyme Disease (LD) Case Report Form PATIENT INFORMATION First Name: Delaware Division of Public Health Bureau of Epidemiology Lyme Disease (LD) Case Report Form PATIENT INFORMATION First Name:](https://www.pdfsearch.io/img/70dbfd6b4df356885f0d58299d52311e.jpg) | Add to Reading ListSource URL: www.dhss.delaware.govLanguage: English - Date: 2008-12-30 14:59:19
|
---|
243![This watermark does not appear in the registered version - http://www.clicktoconvert.com ADVANCED TOPICS IN LYME DISEASE DIAGNOSTIC HINTS AND TREATMENT GUIDELINES FOR LYME AND OTHER This watermark does not appear in the registered version - http://www.clicktoconvert.com ADVANCED TOPICS IN LYME DISEASE DIAGNOSTIC HINTS AND TREATMENT GUIDELINES FOR LYME AND OTHER](https://www.pdfsearch.io/img/50a7fdd7a76f6896ce346b141c2980c0.jpg) | Add to Reading ListSource URL: www.lymediseaseassociation.orgLanguage: English - Date: 2010-07-12 19:06:58
|
---|
244![Clin Rheumatol DOI[removed]s10067[removed]x ORIGINAL ARTICLE The amber theory of Lyme arthritis: initial description Clin Rheumatol DOI[removed]s10067[removed]x ORIGINAL ARTICLE The amber theory of Lyme arthritis: initial description](https://www.pdfsearch.io/img/3b81cc46f89185406181f5939a21acaf.jpg) | Add to Reading ListSource URL: www.aldf.comLanguage: English - Date: 2012-03-22 12:19:10
|
---|
245![HLR[removed]XELODA® (capecitabine) TABLETS DESCRIPTION: XELODA (capecitabine) is a fluoropyrimidine carbamate with antineoplastic HLR[removed]XELODA® (capecitabine) TABLETS DESCRIPTION: XELODA (capecitabine) is a fluoropyrimidine carbamate with antineoplastic](https://www.pdfsearch.io/img/555f2751e1704ea01158df4046ec843a.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 16:58:01
|
---|
246![Microsoft Word - LymeDisease_FAQ_PUB_ENG_0611.doc Microsoft Word - LymeDisease_FAQ_PUB_ENG_0611.doc](https://www.pdfsearch.io/img/12a2532515f3bd26e1672032a8b17929.jpg) | Add to Reading ListSource URL: www.dhss.delaware.govLanguage: English - Date: 2012-01-31 14:45:06
|
---|
247![125-08_CME_eLiteratur_FERTIG.qxd 125-08_CME_eLiteratur_FERTIG.qxd](https://www.pdfsearch.io/img/43b25e4b49788a3ad58be067451d2033.jpg) | Add to Reading ListSource URL: www.aldf.comLanguage: English - Date: 2011-04-14 17:14:21
|
---|
248![Special Webinar on Lyme Disease and Borrelia Persistence Special Webinar on Lyme Disease and Borrelia Persistence](https://www.pdfsearch.io/img/2758e0654c44cee38ea15fdc4cb9b232.jpg) | Add to Reading ListSource URL: www.cdc.govLanguage: English - Date: 2014-06-23 15:21:44
|
---|
249![Alberta Health and Wellness Public Health Notifiable Disease Management Guidelines August[removed]Leprosy Alberta Health and Wellness Public Health Notifiable Disease Management Guidelines August[removed]Leprosy](https://www.pdfsearch.io/img/c1804bfac8910eac361ed432aedb38c5.jpg) | Add to Reading ListSource URL: www.health.alberta.caLanguage: English - Date: 2014-03-15 02:35:44
|
---|
250![State of California—Health and Human Services Agency Local ID Number ___________________________ California Department of Public Health Center for Infectious Diseases State of California—Health and Human Services Agency Local ID Number ___________________________ California Department of Public Health Center for Infectious Diseases](https://www.pdfsearch.io/img/c3600e449b2d7a0aafe451ff9594f3c4.jpg) | Add to Reading ListSource URL: www.cdph.ca.govLanguage: English - Date: 2014-08-01 16:18:04
|
---|